{{Rsnum
|rsid=245201
|Gene=LINC01183
|Chromosome=5
|position=127833520
|Orientation=plus
|GMAF=0.3356
|Gene_s=LINC01183
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.4 | 47.8 | 8.8
| HCB | 27.9 | 51.5 | 20.6
| JPT | 38.9 | 49.6 | 11.5
| YRI | 66.4 | 31.5 | 2.1
| ASW | 52.6 | 40.4 | 7.0
| CHB | 27.9 | 51.5 | 20.6
| CHD | 36.4 | 49.5 | 14.0
| GIH | 20.8 | 48.5 | 30.7
| LWK | 55.5 | 31.8 | 12.7
| MEX | 43.1 | 46.6 | 10.3
| MKK | 35.3 | 49.4 | 15.4
| TSI | 42.6 | 50.5 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19023125
|Trait=Brain imaging in schizophrenia (interaction)
|Title=A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype
|RiskAllele=
|Pval=9E-8
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs245201
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19023125; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype. (Initial Sample Size: 64 cases, 74 cases; Replication Sample Size: NR); (Region: 5q23.2; Reported Gene(s): CTXN3, SLC12A2; Risk Allele: rs245201-?); (p-value= 0.00000009).This variant is associated with Brain imaging in schizophrenia (interaction).
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740327
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs245201
|overall_frequency_n=39
|overall_frequency_d=124
|overall_frequency=0.314516
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=35
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}